nach oben

Current Hypertension Reports

Erschienen in:

01.10.2014 | Preeclampsia (VD Garovic, Section Editor)

Hypertensive Pregnancy Disorders and Future Renal Disease

verfasst von: Steven Wagner, Iasmina Craici

Erschienen in: Current Hypertension Reports | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

Hypertensive pregnancy disorders affect approximately 6 to 8 % of otherwise normal pregnancies. A growing body of evidence links these disorders with the future development of hypertension, coronary disease, cerebrovascular disease, and peripheral arterial disease. Larger studies associating hypertensive pregnancy to future development of renal disease have been lacking until recently, with publication of several compelling studies in the last 5 years. In this review, we will focus on the recent evidence associating hypertensive pregnancy disorders with the future development of chronic kidney disease (CKD) and end-stage renal disease (ESRD), as well as the development of microalbuminuria. We will also attempt to answer whether these renal risks are due to direct effects of hypertension during pregnancy, or whether they are due to shared environmental and genetic risk factors.

Weissgerber TL, Turner ST, Bailey KR, Mosley Jr TH, Kardia SL, Wiste HJ, et al. Hypertension in pregnancy is a risk factor for peripheral arterial disease decades after pregnancy. Atherosclerosis. 2013;229(1):212–6. doi:10.1016/j.atherosclerosis.2013.04.012.PubMedCrossRefPubMedCentral

Garovic VD, Bailey KR, Boerwinkle E, Hunt SC, Weder AB, Curb D, et al. Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J Hypertens. 2010;28(4):826–33. doi:10.1097/HJH.0b013e328335c29a.PubMedCrossRefPubMedCentral

Rochat RW, Koonin LM, Atrash HK, Jewett JF. Maternal mortality in the United States: report from the Maternal Mortality Collaborative. Obstet Gynecol. 1988;72(1):91–7.PubMed

CIA. World Factbook. 2013. https://www.cia.gov/library/publications/the-world-factbook/fields/2054.html.

Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;1(8287):1430–2.PubMedCrossRef

American Diabetes A. Standards of medical care in diabetes—2013. Diabetes Care. 2013;36 Suppl 1:S11–66. doi:10.2337/dc13-S011.CrossRef

Bar J, Kaplan B, Wittenberg C, Erman A, Boner G, Ben-Rafael Z, et al. Microalbuminuria after pregnancy complicated by pre-eclampsia. Nephrol, Dials, Transplant: Off Publ Eur Dial Transplant Assoc - Eur Renal Assoc. 1999;14(5):1129–32.CrossRef

Nisell H, Lintu H, Lunell NO, Mollerstrom G, Pettersson E. Blood pressure and renal function seven years after pregnancy complicated by hypertension. Br J Obstet Gynaecol. 1995;102(11):876–81.PubMedCrossRef

9.•

McDonald SD, Han Z, Walsh MW, Gerstein HC, Devereaux PJ. Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis: Off J Nat Kidney Found. 2010;55(6):1026–39. doi:10.1053/j.ajkd.2009.12.036. The first systematic meta-analysis of smaller studies examining the risk of future microalbuminuria after a preeclamptic pregnancy found that risk was increased 4- to 8-fold for preeclampsia and severe preeclampsia, respectively.CrossRef

10.•

Sandvik MK, Hallan S, Svarstad E, Vikse BE. Preeclampsia and prevalence of microalbuminuria 10 years later. Clin J Am Soc Nephrol: CJASN. 2013;8(7):1126–34. doi:10.2215/CJN.10641012. Examined 89 women with preeclampsia 9–11 years after delivery, compared to 69 normotensive controls. Did not find any difference in albumin excretion between the two groups, although the study might have been underpowered.PubMedCrossRefPubMedCentral

11.•

Kattah AG, Asad R, Scantlebury DC, Bailey KR, Wiste HJ, Hunt SC, et al. Hypertension in pregnancy is a risk factor for microalbuminuria later in life. J Clin Hypertens. 2013;15(9):617–23. doi:10.1111/jch.12116. Examined a large group of 475 women with a history of preeclampsia compared with 2,199 controls. Found a significantly increased risk of microalbuminuria (OR = 1.37).CrossRef

12.•

Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med. 2008;359(8):800–9. doi:10.1056/NEJMoa0706790. One of the first studies to convincingly show an association between past preeclamptic pregnancy and ESRD.PubMedCrossRef

13.•

Wang IK, Muo CH, Chang YC, Liang CC, Chang CT, Lin SY, et al. Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study. CMAJ: Can Med Assoc J = J l'Assoc Med Can. 2013;185(3):207–13. doi:10.1503/cmaj.120230. A study of insurance claim data comparing 26,651 preeclamptic women to 213,397 normotensive controls. The hazard ratio for ESRD was above 12, but fell to 2.72 after controlling for hypertension and diabetes at follow-up.CrossRef

14.•

Wu CC, Chen SH, Ho CH, Liang FW, Chu CC, Wang HY, et al. End-stage renal disease after hypertensive disorders in pregnancy. Am J Obstet Gynecol. 2014;210(2):147–e1-8. doi:10.1016/j.ajog.2013.09.027. Similar to Wang et al. in that the authors examined insurance claim data. Found a 10-fold increase in the incidence of ESRD after preeclamptic pregnancy but, again, was not able to convincingly control for confounding medical conditions.PubMedCrossRef

15.

Craici IM, Wagner SJ, Bailey KR, Fitz-Gibbon PD, Wood-Wentz CM, Turner ST, et al. Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension. 2013;61(6):1289–96. doi:10.1161/HYPERTENSIONAHA.113.01115.PubMedCrossRefPubMedCentral

16.

Aita K, Etoh M, Hamada H, Yokoyama C, Takahashi A, Suzuki T, et al. Acute and transient podocyte loss and proteinuria in preeclampsia. Nephron Clin Pract. 2009;112(2):c65–70. doi:10.1159/000213083.PubMedCrossRef

17.

Zhao S, Gu Y, Coates G, Groome LJ, Saleem MA, Mathieson PW, et al. Altered nephrin and podoplanin distribution is associated with disturbed polarity protein PARD-3 and PARD-6 expressions in podocytes from preeclampsia. Reprod Sci. 2011;18(8):772–80. doi:10.1177/1933719111398145.PubMedCrossRef

18.

White WM, Garrett AT, Craici IM, Wagner SJ, Fitz-Gibbon PD, Butters KA, et al. Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury. PLoS One. 2014;9(3):e92693. doi:10.1371/journal.pone.0092693.PubMedCrossRefPubMedCentral

19.

Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol: JASN. 2005;16(10):2941–52. doi:10.1681/ASN.2005010055.PubMedCrossRef

20.

Ferreira I, Peeters LL, Stehouwer CD. Preeclampsia and increased blood pressure in the offspring: meta-analysis and critical review of the evidence. J Hypertens. 2009;27(10):1955–9. doi:10.1097/HJH.0b013e328331b8c6.PubMedCrossRef

21.•

Davis EF, Lazdam M, Lewandowski AJ, Worton SA, Kelly B, Kenworthy Y, et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics. 2012;129(6):e1552–61. doi:10.1542/peds.2011-3093. A concise review of an important topic, highlighting the various cardiovascular risks that are associated with being born of a preeclamptic pregnancy.PubMedCrossRef

22.

White SL, Perkovic V, Cass A, Chang CL, Poulter NR, Spector T, et al. Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis: Off J Nat Kidney Found. 2009;54(2):248–61. doi:10.1053/j.ajkd.2008.12.042.CrossRef

23.

Hack M, Schluchter M, Cartar L, Rahman M. Blood pressure among very low birth weight (<1.5 kg) young adults. Pediatr Res. 2005;58(4):677–84.PubMedCrossRef

24.

Rotteveel J, van Weissenbruch MM, Twisk JW, Delemarre-Van de Waal HA. Infant and childhood growth patterns, insulin sensitivity, and blood pressure in prematurely born young adults. Pediatrics. 2008;122(2):313–21.PubMedCrossRef

25.

Stelloh C, Allen KP, Mattson DL, Lerch-Gaggl A, Reddy S, El-Meanawy A. Prematurity in mice leads to reduction in nephron number, hypertension, and proteinuria. Transl Res: J Lab Clin Med. 2012;159(2):80–9. doi:10.1016/j.trsl.2011.10.004.CrossRef

26.

Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med. 2003;348(2):101–8. doi:10.1056/NEJMoa020549.PubMedCrossRef

27.

Sullivan A KS, Joshi H. Social class and inequalities in early cognitive scores. Sociology. 2013;47(6).

28.

Gordin D, Hiilesmaa V, Fagerudd J, Ronnback M, Forsblom C, Kaaja R, et al. Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women. Diabetologia. 2007;50(3):516–22. doi:10.1007/s00125-006-0544-5.PubMedCrossRef

29.

Jacquemyn Y, Jochems L, Duiker E, Bosmans JL, Van Hoof V, Van Campenhout C. Long-term renal function after HELLP syndrome. Gynecol Obstet Investig. 2004;57(2):117–20. doi:10.1159/000075942.CrossRef

30.

Lampinen KH, Ronnback M, Kaaja RJ, Groop PH. Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens. 2006;24(4):751–6. doi:10.1097/01.hjh.0000217859.27864.19.PubMedCrossRef

31.

North RA, Simmons D, Barnfather D, Upjohn M. What happens to women with preeclampsia? Microalbuminuria and hypertension following preeclampsia. Aust N Z J Obstet Gynaecol. 1996;36(3):233–8.PubMedCrossRef

32.

Shammas AG, Maayah JF. Hypertension and its relation to renal function 10 years after pregnancy complicated by pre-eclampsia and pregnancy induced hypertension. Saudi Med J. 2000;21(2):190–2.PubMed

Titel: Hypertensive Pregnancy Disorders and Future Renal Disease
verfasst von: Steven Wagner
Iasmina Craici
Publikationsdatum: 01.10.2014
Verlag: Springer US
Erschienen in: Current Hypertension Reports / Ausgabe 10/2014
Print ISSN: 1522-6417
Elektronische ISSN: 1534-3111
DOI: https://doi.org/10.1007/s11906-014-0484-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2014

Treatment of Hypertension and Metabolic Syndrome: Lowering Blood Pressure Is Not Enough for Organ Protection, New Approach-Arterial Destiffening

Ambulatory Blood Pressure Phenotypes and the Risk for Hypertension

Obstructive Sleep Apnea and Hypertension: a Critical Review

Out-of-Office Blood Pressure Improves Risk Stratification in Normotension and Prehypertension People

Resistant or Refractory Hypertension: Are They Different?